Issue
Copyright (c) 2025 Alexander Blagov, Nikolay Orekhov, Dmitry Beloyartsev, Alexey Churov, Tatiana Kovyanova, Irina Starodubtseva, Vasily Sukhorukov, Alexander Orekhov
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The undersigned hereby assign all rights, included but not limited to copyright, for this manuscript to CMB Association upon its submission for consideration to publication on Cellular and Molecular Biology. The rights assigned include, but are not limited to, the sole and exclusive rights to license, sell, subsequently assign, derive, distribute, display and reproduce this manuscript, in whole or in part, in any format, electronic or otherwise, including those in existence at the time this agreement was signed. The authors hereby warrant that they have not granted or assigned, and shall not grant or assign, the aforementioned rights to any other person, firm, organization, or other entity. All rights are automatically restored to authors if this manuscript is not accepted for publication.Analysis of the prospects of new therapeutic agents for the treatment of rheumatoid arthritis
Corresponding Author(s) : Alexander V. Blagov
Cellular and Molecular Biology,
Vol. 71 No. 7: Issue 7
Abstract
Rheumatoid arthritis (RA), a chronic autoimmune disease, is one of the major research themes in medicine. The current therapies have their limitations and cannot completely cure RA, but new therapeutic strategies are being proposed to reduce the shortcomings of approved drugs. This review will consider new potential treatment strategies for RA, including T-cell therapy, genetic editing and epigenetic regulation, what advantages and disadvantages they have and to what pathological target in RA they are directed.
Keywords
Download Citation
Endnote/Zotero/Mendeley (RIS)BibTeX
